PSG Global Solutions
Site Start-Up Specialist
PSG Global Solutions, Irvine, California, United States, 92713
DescriptionWe're looking for a
Site Start-Up Specialist , working in
Pharmaceuticals and Medical Products
industry in
Irvine, California, United States .Job description:
Provides support and/or leadership to their assigned Site Start Up Teams in the execution of all Site Start Up activities and timely initiation of sites for clinical trials.Performs all the roles encompassed in the preceding grade levels within the job family as required by the organization. Conduct their work activities in compliance with all relevant laws, regulations, and regulatory guidelines as well as all company policies and procedures.Directly manages clinical site initiation activities.Reviews approval of clinical study informed consent forms and patient privacy authorization forms.Ensures all required documentation and training has been properly executed, received in-house and filed appropriately. Completes all required debarment and medical license checks.Assures all requirements are met for IP release.
#J-18808-Ljbffr
Site Start-Up Specialist , working in
Pharmaceuticals and Medical Products
industry in
Irvine, California, United States .Job description:
Provides support and/or leadership to their assigned Site Start Up Teams in the execution of all Site Start Up activities and timely initiation of sites for clinical trials.Performs all the roles encompassed in the preceding grade levels within the job family as required by the organization. Conduct their work activities in compliance with all relevant laws, regulations, and regulatory guidelines as well as all company policies and procedures.Directly manages clinical site initiation activities.Reviews approval of clinical study informed consent forms and patient privacy authorization forms.Ensures all required documentation and training has been properly executed, received in-house and filed appropriately. Completes all required debarment and medical license checks.Assures all requirements are met for IP release.
#J-18808-Ljbffr